XML 29 R15.htm IDEA: XBRL DOCUMENT v3.19.3
RECEIVABLES
 9 Months Ended
Sep. 30, 2019
Accounts Receivable, after Allowance for Credit Loss [Abstract]  
Receivables [Text Block] RECEIVABLES
Dollars in Millions
September 30,
2019
 
December 31,
2018
Trade receivables
$
4,595

 
$
4,914

Less charge-backs and cash discounts
(270
)
 
(245
)
Less bad debt allowances
(36
)
 
(33
)
Net trade receivables
4,289

 
4,636

Prepaid and refundable income taxes
159

 
218

Alliance, royalties, VAT and other
1,062

 
1,111

Receivables
$
5,510

 
$
5,965



Non-U.S. receivables sold on a nonrecourse basis were $580 million and $594 million for the nine months ended September 30, 2019 and 2018, respectively. Receivables from the Company's three largest pharmaceutical wholesalers in the U.S. represented approximately 70% of total trade receivables at September 30, 2019 and December 31, 2018.